Edoxaban in acute PE and DVT: Focus on the Hokusai-VTE Study
Edoxaban in acute PE and DVT: Focus on the Hokusai-VTE Study
This feature requires the newest version of Flash. You can download it here.
ESC Congress 2013 was buzzing with the results of the Hokusai-VTE Study. From the convention floor, Dr Samuel Goldhaber shares his excitement for the new NOA kid on the block.
See:
Hokusai-VTE Study: Once-daily edoxaban matches warfarin for averting recurrent DVT, PE
The Hokusai-VTE investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. New Engl J Med 2013; DOI:10.1056/NEJMoa1306638. Available at: http://www.nejm.org.
This feature requires the newest version of Flash. You can download it here.
ESC Congress 2013 was buzzing with the results of the Hokusai-VTE Study. From the convention floor, Dr Samuel Goldhaber shares his excitement for the new NOA kid on the block.
See:
Hokusai-VTE Study: Once-daily edoxaban matches warfarin for averting recurrent DVT, PE
The Hokusai-VTE investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. New Engl J Med 2013; DOI:10.1056/NEJMoa1306638. Available at: http://www.nejm.org.
